iRadimed
IRMD
$44.70
Share price
1.94%
Change (1 day)
3.59%
Change (1 year)
Categories
iRadimed (IRMD) - P/B ratio
P/B ratio as of May 2024 : 7.76
According to iRadimed's latest financial reports the company has a price-to-book ratio of 7.76.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
iRadimed - P/B ratio (from 2014 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 8.38 | 73.63% |
| 2022-12-31 | 4.83 | -39.92% |
| 2021-12-31 | 8.03 | 75.68% |
| 2020-12-31 | 4.57 | -7.72% |
| 2019-12-31 | 4.95 | -22.69% |
| 2018-12-31 | 6.41 | 31.96% |
| 2017-12-31 | 4.86 | 30.23% |
| 2016-12-31 | 3.73 | -61.99% |
| 2015-12-31 | 9.81 | 46.89% |
| 2014-12-31 | 6.68 | |
| 2013-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Edwards Lifesciences EW | 7.63 | -1.74% | 🇺🇸 USA |
 NuVasive NUVA | 2.34 | -69.91% | 🇺🇸 USA |
 DexCom DXCM | 22.4 | 188.76% | 🇺🇸 USA |
 AtriCure ATRC | 2.31 | -70.30% | 🇺🇸 USA |